Elesclomol 10 mg | 99.33%
TargetMol
Elesclomol (STA-4783) is an effective oxidative stress inducer that elicits pro-apoptosis of tumor cells.
More Information Supplier PageElesclomol
Search Results
LDN-193189 HCl 5 mg | 100.00%
TargetMol
LDN193189 hydrochloride is a selective BMP type I receptor kinases inhibitor.
More Information Supplier PageLDN-193189 HCl
LDN-193189 HCl 2 mg | 100.00%
TargetMol
LDN193189 hydrochloride is a selective BMP type I receptor kinases inhibitor.
More Information Supplier PageLDN-193189 HCl
LDN-193189 HCl 10 mg | 100.00%
TargetMol
LDN193189 hydrochloride is a selective BMP type I receptor kinases inhibitor.
More Information Supplier PageLDN-193189 HCl
Entospletinib 5 mg | 99.05%
TargetMol
Entospletinib （IC50= 7.7 nM）is a specific Syk inhibitor, which is orally bioavailable.
More Information Supplier PageEntospletinib
Entospletinib 50 mg | 99.05%
TargetMol
Entospletinib （IC50= 7.7 nM）is a specific Syk inhibitor, which is orally bioavailable.
More Information Supplier PageEntospletinib
Entospletinib 200 mg | 99.05%
TargetMol
Entospletinib （IC50= 7.7 nM）is a specific Syk inhibitor, which is orally bioavailable.
More Information Supplier PageEntospletinib
SB756050 10 mg | 98.35%
TargetMol
SB756050
SPI-112 25 mg | Purity Not Available
TargetMol
SPI-112, the SPI-112 methyl ester analog, can inhibit cellular Shp2 PTP activity. SPI-112 bound to Shp2 by surface plasmon resonance (SPR) and displayed competitive inhibitor kinetics to Shp2.
More Information Supplier PageSPI-112
SPI-112 10 mg | Purity Not Available
TargetMol
SPI-112, the SPI-112 methyl ester analog, can inhibit cellular Shp2 PTP activity. SPI-112 bound to Shp2 by surface plasmon resonance (SPR) and displayed competitive inhibitor kinetics to Shp2.
More Information Supplier PageSPI-112